Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense youโre witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26